Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
VSTM Verastem Inc
- Stocks
- Healthcare
- NASDAQ: VSTM
Price (delayed)
$7.59
Market cap
$417.06M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.42
Enterprise value
$376.05M
Verastem Oncology is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. The company's pipeline is focused on
Highlights
Verastem's EPS has increased by 22% YoY and by 7% QoQ
Verastem's quick ratio has decreased by 20% YoY but it has increased by 15% from the previous quarter
Verastem's debt has soared by 82% from the previous quarter and by 82% YoY
VSTM's net income is down by 41% year-on-year and by 14% since the previous quarter
Key stats
What are the main financial stats of VSTM
Market
Valuations
Earnings
Shares outstanding
54.95M
Market cap
$417.06M
Enterprise value
$376.05M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
41.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
37.6
Revenue
$10M
Gross profit
$10M
Operating income
-$131.08M
Net income
-$148.88M
EBIT
-$145.07M
EBITDA
-$145.19M
Free cash flow
-$115.15M
Per share
Balance sheet
Liquidity
EPS
-$3.42
EPS diluted
-$3.42
Free cash flow per share
-$2.13
Book value per share
-$0.63
Revenue per share
$0.18
TBVPS
$2.43
Total assets
$131.7M
Total liabilities
$164.13M
Debt
$76.8M
Equity
-$32.43M
Working capital
$89.08M
Debt to equity
-2.37
Current ratio
3.5
Quick ratio
3.31
Net debt/EBITDA
0.28
Margins
Efficiency
Dividend
EBITDA margin
-1,451.9%
Gross margin
100%
Net margin
-1,488.8%
Operating margin
-1,310.8%
Return on assets
-128%
Return on equity
N/A
Return on invested capital
-447.3%
Return on capital employed
-151%
Return on sales
-1,450.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VSTM stock price
How has the Verastem stock price performed over time
Intraday
-4.29%
1 week
5.86%
1 month
53.02%
1 year
-37.43%
YTD
46.81%
QTD
25.87%
Financial performance
How have Verastem's revenue and profit performed over time
Revenue
$10M
Gross profit
$10M
Operating income
-$131.08M
Net income
-$148.88M
Gross margin
100%
Net margin
-1,488.8%
VSTM's net income is down by 41% year-on-year and by 14% since the previous quarter
The company's operating income fell by 30% YoY and by 14% QoQ
Verastem's net margin has decreased by 14% from the previous quarter
Verastem's operating margin has decreased by 14% from the previous quarter
Price vs fundamentals
How does VSTM's price correlate with its fundamentals
Growth
What is Verastem's growth rate over time
Valuation
What is Verastem stock price valuation
P/E
N/A
P/B
N/A
P/S
41.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
37.6
Verastem's EPS has increased by 22% YoY and by 7% QoQ
Verastem's equity has decreased by 12% QoQ
The price to sales (P/S) is 131% higher than the last 4 quarters average of 17.8
Efficiency
How efficient is Verastem business performance
The ROA has plunged by 95% YoY and by 12% from the previous quarter
The ROIC has contracted by 17% from the previous quarter
Verastem's return on sales has decreased by 15% QoQ
Dividends
What is VSTM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VSTM.
Financial health
How did Verastem financials performed over time
The total assets is 20% smaller than the total liabilities
Verastem's total liabilities has soared by 112% YoY and by 26% from the previous quarter
The total assets has increased by 30% since the previous quarter and by 7% year-on-year
Verastem's debt has soared by 82% from the previous quarter and by 82% YoY
VSTM's debt to equity has dropped by 62% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.